Enliven Therapeutics, Inc. (ELVN)
NASDAQ·Healthcare·Biotechnology
$46.17
-4.18%
Mkt Cap $3.49B
Analyst Ratings
Buy
10
Hold
0
Sell
0
Price Target (12 analysts)
$69.20
Range $59.00 – $80.00
Implied Upside
+49.9%
Consensus $69.20 vs current $46.17
NASDAQ·Healthcare·Biotechnology
$46.17
-4.18%
Mkt Cap $3.49B
Buy
10
Hold
0
Sell
0
Price Target (12 analysts)
$69.20
Range $59.00 – $80.00
+49.9%
Consensus $69.20 vs current $46.17